affairs, and compliance professionals, detailing the objectives, documentation, roles, and inspection expectations associated with these systems.

Step 1: Understanding Regulatory Frameworks

The first phase in developing a combined and companion QMS is to understand the regulatory frameworks that govern medical devices and combination products. In the United States, the FDA regulates these products under the Federal Food, Drug, and Cosmetic Act. In the European Union, the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) set forth the requirements. The UK follows similar guidelines post-Brexit, with the MHRA overseeing compliance.

Objectives: The primary objective of this step is to familiarize your team with the relevant regulations and standards that apply to your products. This includes understanding the differences between device classifications and the associated regulatory pathways.

Documentation: Key documents include the FDA’s guidance on combination products, the EU MDR, and ISO 13485:2016, which outlines requirements for a QMS specific to medical devices.

Roles: Regulatory affairs professionals should lead this phase, supported by quality managers and compliance officers.

Inspection Expectations: During inspections, auditors will expect evidence of understanding and compliance with applicable regulations. This includes documentation of training sessions and regulatory updates.

Step 2: Developing a Risk Management Plan

Risk management is a critical component of a combined and companion QMS. According to ISO 14971, manufacturers must establish a process for risk management throughout the product lifecycle. This step involves identifying hazards, estimating and evaluating risks, and implementing controls.

Objectives: The goal is to create a comprehensive risk management plan that identifies potential risks associated with your products and outlines mitigation strategies.

Documentation: The risk management plan should include risk analysis reports, risk evaluation matrices, and documentation of risk control measures.

Roles: Quality managers and product development teams should collaborate to ensure that risk management is integrated into the product design and development processes.

Inspection Expectations: Auditors will review the risk management documentation to ensure that all identified risks have been addressed and that appropriate controls are in place. They may also assess the effectiveness of the risk management process during product development.

Step 3: Establishing Quality Management Processes

Once the regulatory framework and risk management strategies are in place, the next step is to establish quality management processes. This includes defining procedures for document control, change management, and non-conformance management.

Objectives: The objective is to create standardized processes that ensure consistent quality and compliance across all operations.

Documentation: Essential documents include Standard Operating Procedures (SOPs), work instructions, and forms for documenting non-conformances and corrective actions.

Roles: Quality managers should oversee the development of these processes, with input from various departments such as manufacturing, regulatory affairs, and quality control.

Inspection Expectations: Inspectors will evaluate the effectiveness of your quality management processes. They will look for evidence of adherence to SOPs and the handling of non-conformances, including corrective and preventive actions.

Step 4: Training and Competence Assessment

Training is vital to ensure that all personnel involved in the QMS understand their roles and responsibilities. A well-trained workforce is essential for maintaining compliance and ensuring product quality.

Objectives: The goal is to implement a training program that covers regulatory requirements, quality management processes, and specific job functions.

Documentation: Training records should be maintained for all employees, including training materials, attendance logs, and assessments of competence.

Roles: Quality managers should coordinate training efforts, while department heads are responsible for ensuring their teams receive the necessary training.

Inspection Expectations: Auditors will review training records to verify that employees are adequately trained for their roles. They may also conduct interviews to assess employees’ understanding of the QMS and their responsibilities.

Step 5: Implementing Internal Audits

Internal audits are a critical component of a combined and companion QMS, providing a systematic approach to evaluating compliance and identifying areas for improvement. Regular audits help ensure that the QMS is functioning effectively and that any issues are addressed promptly.

Objectives: The objective is to establish a schedule for internal audits and develop a process for conducting audits that align with regulatory requirements.

Documentation: Audit plans, checklists, and reports should be documented to provide a clear record of audit activities and findings.

Roles: Quality managers typically lead internal audits, with participation from cross-functional teams to ensure a comprehensive evaluation.

Inspection Expectations: During inspections, auditors will review internal audit reports and corrective action plans to assess the effectiveness of the audit process and the organization’s commitment to continuous improvement.

Step 6: Management Review and Continuous Improvement

Management review is essential for ensuring that the QMS remains effective and aligned with organizational goals. This step involves evaluating the performance of the QMS and identifying opportunities for improvement.

Objectives: The goal is to conduct regular management reviews that assess the effectiveness of the QMS and drive continuous improvement initiatives.

Documentation: Management review meeting minutes, performance metrics, and action plans for improvement should be documented and maintained.

Roles: Senior management should participate in management reviews, supported by quality managers who provide data and insights on QMS performance.

Inspection Expectations: Auditors will expect to see evidence of management reviews and the actions taken as a result. They will assess whether the organization is committed to continuous improvement and compliance with regulatory requirements.

Conclusion

Establishing a combined and companion QMS for medical devices and combination products is a complex but essential undertaking for organizations operating in regulated industries. By following the steps outlined in this tutorial, quality managers, regulatory affairs, and compliance professionals can ensure that their QMS meets the expectations of the FDA, EMA, and MHRA. A robust QMS not only facilitates compliance but also enhances product quality and safety, ultimately benefiting patients and healthcare providers alike.

For further guidance on regulatory compliance, refer to the FDA’s guidance on combination products and the EMA’s guidelines on combination products.